Magnesium orotate in severe congestive heart failure (MACH) (DOI:10.1016/j.ijcard.2007.11.022)

International Journal of Cardiology

Volumn 134, Issue 1, 2009, Pages 145-147

  Stepura, O B ^a   Martynow, A I ^b  

^a Russian University of Medicine   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Adjuvant therapy; Congestive heart failure; Magnesium; Magnesium orotate; Orotic acid

Indexed keywords

CREATININE; OROTATE MAGNESIUM;

ADJUVANT THERAPY; ADULT; AGED; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETERIORATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; ERRATUM; FEMALE; HEPATOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OROTIC ACID; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 64149123033     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.01.047     Document Type: Erratum

References (5)

1. Gartside P.S., and Glueck C.J. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr 14 (1995) 71-79
2. Richards S.M., Conyers R.A., Fisher J.L., and Rosenfeldt F.L. Cardioprotection by orotic acid: metabolism and mechanism of action. J Mol Cell Cardiol 29 (1997) 3239-3250
3. Rosenfeldt F.L. Metabolic supplementation with orotic acid and magnesium orotate. Cardiovasc Drugs Ther 12 Suppl 2 (1998) 147-152
4. Classen H.G. Magnesium orotate-experimental and clinical evidence. Rom J Intern Med 42 (2004) 491-501
5. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150